Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 76

1.

Sex and Gender Differences in the Outcomes of Vaccination over the Life Course.

Flanagan KL, Fink AL, Plebanski M, Klein SL.

Annu Rev Cell Dev Biol. 2017 Oct 6;33:577-599. doi: 10.1146/annurev-cellbio-100616-060718.

PMID:
28992436
2.

Minimal Sex-Differential Modulation of Reactivity to Pathogens and Toll-Like Receptor Ligands following Infant Bacillus Calmette-Guérin Russia Vaccination.

Darboe F, Adetifa JU, Reynolds J, Hossin S, Plebanski M, Netea MG, Rowland-Jones SL, Sutherland JS, Flanagan KL.

Front Immunol. 2017 Sep 8;8:1092. doi: 10.3389/fimmu.2017.01092. eCollection 2017.

3.

Negative Correlation between Circulating CD4+FOXP3+CD127- Regulatory T Cells and Subsequent Antibody Responses to Infant Measles Vaccine but Not Diphtheria-Tetanus-Pertussis Vaccine Implies a Regulatory Role.

Ndure J, Noho-Konteh F, Adetifa JU, Cox M, Barker F, Le MT, Sanyang LC, Drammeh A, Whittle HC, Clarke E, Plebanski M, Rowland-Jones SL, Flanagan KL.

Front Immunol. 2017 Aug 14;8:921. doi: 10.3389/fimmu.2017.00921. eCollection 2017.

4.

Measles Vaccination Is Effective at Under Nine Months of Age, and Provides Nonspecific Immunological Benefits.

Flanagan KL.

J Infect Dis. 2017 Apr 15;215(8):1177-1178. doi: 10.1093/infdis/jiw594. No abstract available.

PMID:
28368539
5.
6.

The Economics of Malaria Vaccine Development.

Plebanski M, Flanagan KL.

Trends Parasitol. 2017 Mar;33(3):154-156. doi: 10.1016/j.pt.2017.01.006. Epub 2017 Feb 3.

PMID:
28169112
7.

Viral Vector Malaria Vaccines Induce High-Level T Cell and Antibody Responses in West African Children and Infants.

Bliss CM, Drammeh A, Bowyer G, Sanou GS, Jagne YJ, Ouedraogo O, Edwards NJ, Tarama C, Ouedraogo N, Ouedraogo M, Njie-Jobe J, Diarra A, Afolabi MO, Tiono AB, Yaro JB, Adetifa UJ, Hodgson SH, Anagnostou NA, Roberts R, Duncan CJ, Cortese R, Viebig NK, Leroy O, Lawrie AM, Flanagan KL, Kampmann B, Imoukhuede EB, Sirima SB, Bojang K, Hill AV, Nébié I, Ewer KJ.

Mol Ther. 2017 Feb 1;25(2):547-559. doi: 10.1016/j.ymthe.2016.11.003.

8.

The global challenge and future strategies for keeping the world's aging population healthy by vaccination.

Steeper M, Plebanski M, Flanagan KL.

Trans R Soc Trop Med Hyg. 2016 Aug;110(8):427-31. doi: 10.1093/trstmh/trw054. Epub 2016 Sep 12. No abstract available.

PMID:
27618919
9.

Sex differences in immune responses.

Klein SL, Flanagan KL.

Nat Rev Immunol. 2016 Oct;16(10):626-38. doi: 10.1038/nri.2016.90. Epub 2016 Aug 22. Review.

PMID:
27546235
10.

Sex-Differential Non-Vaccine-Specific Immunological Effects of Diphtheria-Tetanus-Pertussis and Measles Vaccination.

Noho-Konteh F, Adetifa JU, Cox M, Hossin S, Reynolds J, Le MT, Sanyang LC, Drammeh A, Plebanski M, Forster T, Dickinson P, Ghazal P, Whittle H, Rowland-Jones SL, Sutherland JS, Flanagan KL.

Clin Infect Dis. 2016 Nov 1;63(9):1213-1226. Epub 2016 Jul 19.

PMID:
27436422
11.

Sex-differential heterologous (non-specific) effects of vaccines: an emerging public health issue that needs to be understood and exploited.

Flanagan KL, Plebanski M.

Expert Rev Vaccines. 2017 Jan;16(1):5-13. Epub 2016 Jun 30. Review.

PMID:
27362915
12.

Safety and Immunogenicity of ChAd63 and MVA ME-TRAP in West African Children and Infants.

Afolabi MO, Tiono AB, Adetifa UJ, Yaro JB, Drammeh A, Nébié I, Bliss C, Hodgson SH, Anagnostou NA, Sanou GS, Jagne YJ, Ouedraogo O, Tamara C, Ouedraogo N, Ouedraogo M, Njie-Jobe J, Diarra A, Duncan CJ, Cortese R, Nicosia A, Roberts R, Viebig NK, Leroy O, Lawrie AM, Flanagan KL, Kampman B, Bejon P, Imoukhuede EB, Ewer KJ, Hill AV, Bojang K, Sirima SB.

Mol Ther. 2016 Aug;24(8):1470-7. doi: 10.1038/mt.2016.83. Epub 2016 Apr 25.

13.

Changing oral vaccine to inactivated polio vaccine might increase mortality.

Fish EN, Flanagan KL, Furman D, Klein SL, Kollmann TR, Jeppesen DL, Levy O, Marchant A, Namachivayam S, Netea MG, Plebanski M, Rowland-Jones SL, Selin LK, Shann F, Whittle HC.

Lancet. 2016 Mar 12;387(10023):1054-1055. doi: 10.1016/S0140-6736(16)00661-9. No abstract available.

14.

Timing of routine infant vaccinations and risk of food allergy and eczema at one year of age.

Kiraly N, Koplin JJ, Crawford NW, Bannister S, Flanagan KL, Holt PG, Gurrin LC, Lowe AJ, Tang ML, Wake M, Ponsonby AL, Dharmage SC, Allen KJ.

Allergy. 2016 Apr;71(4):541-9. doi: 10.1111/all.12830. Epub 2016 Feb 8.

PMID:
26707796
15.

Polymorphism in liver-stage malaria vaccine candidate proteins: immune evasion and implications for vaccine design.

Flanagan KL, Wilson KL, Plebanski M.

Expert Rev Vaccines. 2016;15(3):389-99. doi: 10.1586/14760584.2016.1125785. Epub 2015 Dec 23. Review.

PMID:
26610026
16.

Whole blood gene expression profiling of neonates with confirmed bacterial sepsis.

Dickinson P, Smith CL, Forster T, Craigon M, Ross AJ, Khondoker MR, Ivens A, Lynn DJ, Orme J, Jackson A, Lacaze P, Flanagan KL, Stenson BJ, Ghazal P.

Genom Data. 2014 Nov 15;3:41-8. doi: 10.1016/j.gdata.2014.11.003. eCollection 2015 Mar.

17.

Early virological and immunological events in asymptomatic Epstein-Barr virus infection in African children.

Jayasooriya S, de Silva TI, Njie-jobe J, Sanyang C, Leese AM, Bell AI, McAulay KA, Yanchun P, Long HM, Dong T, Whittle HC, Rickinson AB, Rowland-Jones SL, Hislop AD, Flanagan KL.

PLoS Pathog. 2015 Mar 27;11(3):e1004746. doi: 10.1371/journal.ppat.1004746. eCollection 2015 Mar.

18.

Vaccines have sex differential non-targeted heterologous effects: a new dawn in vaccine research.

Flanagan KL.

Trans R Soc Trop Med Hyg. 2015 Jan;109(1):1-2. doi: 10.1093/trstmh/tru188. No abstract available.

PMID:
25573102
19.

Heterologous and sex differential effects of administering vitamin A supplementation with vaccines.

Jensen KJ, Ndure J, Plebanski M, Flanagan KL.

Trans R Soc Trop Med Hyg. 2015 Jan;109(1):36-45. doi: 10.1093/trstmh/tru184. Epub 2014 Dec 3. Review.

20.

Targeting regulatory T cells to improve vaccine immunogenicity in early life.

Ndure J, Flanagan KL.

Front Microbiol. 2014 Sep 11;5:477. doi: 10.3389/fmicb.2014.00477. eCollection 2014. Review.

Supplemental Content

Loading ...
Support Center